A population-based cross-sectional study of the association between facial morphology and cardiometabolic risk factors in adolescence by Djordjevic, J. et al.
PUBLISHED VERSION  
http://hdl.handle.net/2440/98908 
 
Jelena Djordjevic, Debbie A Lawlor, Alexei I Zhurov, Arshed M Toma, Rebecca Playle, Stephen 
Richmond 
A population-based cross-sectional study of the association between facial morphology and 
cardiometabolic risk factors in adolescence 
BMJ Open, 2013; 3(5):e002910-1-e002910-10 
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-
commercial License, which permits use, distribution, and reproduction in any medium, provided the 
original work is properly cited, the use is non commercial and is otherwise in compliance with the 
license. See: http://creativecommons.org/licenses/by-nc/3.0/ and 
http://creativecommons.org/licenses/by-nc/3.0/legalcode 
 





























study of the association between facial
morphology and cardiometabolic risk
factors in adolescence
Jelena Djordjevic,1 Debbie A Lawlor,2,3 Alexei I Zhurov,1 Arshed M Toma,1
Rebecca Playle,1 Stephen Richmond1
To cite: Djordjevic J,
Lawlor DA, Zhurov AI, et al.
A population-based cross-








▸ Prepublication history for
this paper are available
online. To view these files
please visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-002910).
Received 19 March 2013
Revised 4 April 2013
Accepted 4 April 2013
This final article is available






Clinical Research and Public
Health, School of Dentistry,
Cardiff University, Cardiff, UK




3School of Social and
Community Medicine,






Objective: To determine whether facial morphology is
associated with fasting insulin, glucose and lipids
independent of body mass index (BMI) in adolescents.
Design: Population-based cross-sectional study.
Setting: Avon Longitudinal Study of Parents and
Children (ALSPAC), South West of England.
Participants: From the ALSPAC database of 4747
three-dimensional facial laser scans, collected during a
follow-up clinic at the age of 15, 2348 white British
adolescents (1127 males and 1221 females) were
selected on the basis of complete data on
cardiometabolic parameters, BMI and Tanner’s pubertal
stage.
Main outcome measures: Fasting insulin, glucose
and lipids (triglycerides, high-density lipoprotein
cholesterol (HDLc) and low-density lipoprotein
cholesterol (LDLc)).
Results: On the basis of the collection of 63 x, y and
z coordinates of 21 anthropometric landmarks, 14
facial principal components (PCs) were identified.
These components explained 82% of the variation in
facial morphology and were used as exposure
variables. With adjustment for age, gender and
pubertal stage, seven PCs were associated with fasting
insulin, none with glucose, three with triglycerides,
three with HDLc and four with LDLc. After additional
adjustment for BMI, four PCs remained associated with
fasting insulin, one with triglycerides and two with
LDLc. None of these associations withstood
adjustment for multiple comparisons.
Conclusions: These initial hypotheses generating
analyses provide no evidence that facial morphology is
importantly related to cardiometabolic outcomes.
Further examination might be warranted. Facial
morphology assessment may have value in identifying
other areas of disease risk.
INTRODUCTION
Recent technological advancements in
imaging methods marked a transition from a
two-dimensional to three-dimensional (3D)
ARTICLE SUMMARY
Article focus
▪ Three-dimensional imaging opens up a new chapter
in investigations of facial morphology. Previous
research revealed associations of facial morphology
with obesity in adolescents, but whether facial
morphology can be used to identify those at future
risk of adverse cardiometabolic outcomes is
unknown.
Key messages
▪ Our results suggest that facial morphology is not
strongly or consistently associated with fasting
insulin, glucose or lipids, particularly after adjust-
ment for body mass index, in white British adoles-
cents. Facial morphology is therefore unlikely to be
useful in identifying white British adolescents at
future risk of adverse cardiometabolic outcomes.
▪ A suggested methodology can be used in future
studies to explore the associations between facial
parameters and other health outcomes. It might
provide valuable insights into how facial morph-
ology can be indicative of health.
Strengths and limitations of this study
▪ The strengths of this study are a large sample size
and the homogeneity of the sample: all participants
were of white origin, born and brought up in the
same region of the UK. A non-invasive, accurate
and reliable method was used for capturing details
of facial soft tissue morphology. A comprehensive
statistical analysis was undertaken to extract princi-
pal components of facial morphology.
▪ The study has some limitations. First of all, the study
is ethnic-specific. Second, a face could not be easily
represented as a single exposure due to the complex-
ity of its morphology and the vast amount of data cap-
tured by the laser scanning system. Therefore, some
data reduction was necessary prior to the analysis.
Furthermore, it was not possible to control all the con-
founding factors in a cross-sectional study design.
Since faces of adolescents are still developing, chan-
ging their shape and size, future studies might have to
investigate the relationship between these changes
and cardiometabolic characteristics over time.
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approach in craniofacial research, thus opening a new
era. A special emphasis has been placed on the develop-
ment and application of non-invasive methods to capture
the human face accurately and reliably.1 2 Among these,
laser surface scanning and stereophotogrammetry have
gained wide acceptance of the research community.3 So
far, a large spectrum of medical disciplines have utilised
these methods in the investigations of facial growth, facial
dysmorphology, craniofacial identiﬁcation, as well as the
inﬂuence of different medical conditions on facial
phenotype.4–12 Therefore, an exciting opportunity has
occurred to explore whether facial characteristics can
serve as new diagnostic measures of illnesses.
Childhood obesity is becoming an epidemic health
problem.13 It is evident from many studies that it is asso-
ciated with an increased risk of type 2 diabetes and car-
diovascular disease later in life.14–16 Despite this fact, the
relation between obesity and craniofacial development
has been rarely investigated. Bimaxillary prognathism
(overdeveloped jaws in the sagittal direction) and
increased transverse facial dimensions seem to indicate
the difference between obese adolescents and their
normal-weighted peers.17–19 However, the association
between metabolic phenotype and facial form has not
been addressed previously.
In order to investigate this problem, a large sample
and a comprehensive 3D approach to facial measure-
ments are needed. In this cross-sectional study, which
can be considered to be hypothesis generating, we
examined the associations of facial soft tissue morph-
ology with metabolic phenotype (fasting insulin,
glucose, triglycerides, high-density lipoprotein choles-
terol (HDLc) and low-density lipoprotein cholesterol
(LDLc)) in a large general population cohort of adoles-
cents using an existing database of 3D facial laser scans.
MATERIAL AND METHODS
Sample
We used the data from the Avon Longitudinal Study
of Parents and Children (ALSPAC), a UK-based longitu-
dinal birth cohort study designed to explore genetic and
environmental inﬂuences on health and well-being.20 21 All
pregnant women were eligible to participate in ALSPAC if
their estimated delivery date fell between 1 April 1991 and
31 December 1992, inclusive. In total, 14 541 pregnant
women were recruited, and from these women there were
14 676 live-born infants. Since age 7, surviving offspring
have been invited to regular follow-up clinics.
The current study was approved by the ALSPAC Law
and Ethics Committee and the Local Research Ethics
Committee and informed consent was obtained from
children and their parents or guardians. The data col-
lected during an annual follow-up clinic at the age of
15, which was attended by 5235 adolescents, were exam-
ined. On that occasion, facial laser scanning was per-
formed, and after a dropout of 488 individuals due to
the low quality of the scans or some sort of facial
dysmorphology, a database of 4747 individuals (2233
males and 2514 females) was formed.22 Out of these, we
selected 2348 white adolescents (1127 males and 1221
females), with complete data related to the outcome
and confounding variables (see below), as facial laser
scans were used to derive exposure variables. The ﬂow
chart diagram (ﬁgure 1) shows a gradual selection of
individuals who comprised the ﬁnal sample. In order to
make sure that there was no selection bias, we ﬁrst com-
pared facial principal components (PCs; ie, exposure
variables; see below) of the study sample (2348 adoles-
cents) with those of 4747 adolescents forming a 3D
facial database22 and concluded that there was no
reason to believe that selected individuals were signiﬁ-
cantly different in terms of facial morphology. Second,
we compared observed values for outcomes and con-
founding variables in the study sample (2348 adoles-
cents) with imputed variables in the eligible sample of
the follow-up clinic (5235 adolescents), which were pub-
lished as supplementary online material of the previous
study.23 The distributions in imputed datasets were very
similar to those observed, providing some evidence that
the missing data were missing at random.
Measures
Exposure variables
Facial laser scans were used to derive PCs of facial
morphology, which served as the exposure variables.
This is explained in detail in the section on statistical
analysis. Prior to this, it was necessary to perform three
steps, which will be described here. First of all, facial
scans were processed. The validity and reliability of the
laser scanning procedure, as well as the processing
stages of the scans, have been previously investigated.24–
27 Second, 21 anthropometric landmarks were manually
identiﬁed on facial scans by one experienced examiner
(ﬁgure 2), according to their respective deﬁnitions by
Farkas,28 and their x, y and z coordinates were saved for
the subsequent analysis. Previous research showed that
these landmarks are clinically reliable.29 30 Finally, facial
scans were initially normalised according to the natural
head position, with the origin of the coordinate system
set at the point halfway between the inner corners of the
eyes (mid-endocanthion). The x-axis was pointing left,
from the right eye to the left eye, the y-axis was pointing
vertically upwards from the chin to the forehead and
the z-axis was pointing outwards, in the nose direction.
The coronal, sagittal and transverse planes were taken as
the xy, yz and xz planes, respectively.1 2 8 22 29
Outcome variables
Fasting insulin, fasting glucose, triglycerides, HDLc and
LDLc were taken as the outcome variables. Full details
of their assessment have been previously reported.23
Confounding variables
Since this study is exploratory (being the ﬁrst to
examine these associations) and our main motivation
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was to understand whether facial morphology might be
able to predict those at risk of cardiometabolic disease
over and above simple measurement of adiposity, we did
not adjust for a wide range of confounding variables.
However, we adjusted for age, pubertal stage and body
mass index (BMI), as these are potentially important
predictors of cardiometabolic risk and we would want to
be clear that facial morphology predicted outcome over
and above these. The age of the participants was
recorded in months as they arrived at the clinic.
Pubertal status was assessed on participants’ self report
with Tanner’s questionnaires.
Statistical analyses
Participant characteristics were summarised with means
(SD) for continuous, approximately normally distributed
variables, median (IQR) for continuous right skewed
variables, and the number (%) of categorical variables.
Generalised Procrustes Analysis (GPA) was performed
on landmark conﬁgurations (each consisting of 63 x, y
and z coordinates of 21 facial landmarks) in order to
remove differences in landmark positions attributable to
translation and rotation.31–33 Scaling was not performed
in order to preserve facial size. Principal Component
Analysis (PCA) was used to reduce the set of 63 coordi-
nates into a smaller number of independent compo-
nents of facial morphology. According to the
‘Kaiser-Guttman criterion’, PCs with eigenvalues greater
than the average eigenvalue value were retained34–36
and saved as new exposure variables. The rotation
method used for PCA was varimax with Kaiser normalisa-
tion.37 GPA was performed in the open source software
R project and PCA in SPSS V.17.0 (SPSS Inc, Chicago,
Illinois, USA).
While this is a cross-sectional study, in all our analyses
we examined the association of PCs of facial morphology
(as exposures) with fasting insulin, glucose, triglycerides,
HDLc and LDLc (as outcomes) using multivariable
linear regression models. No evidence was found for any
gender interactions (all p values ≥0.1), and therefore
analyses are presented with both genders combined. In
the ﬁrst model, we adjusted for age, gender and
Figure 1 Flow chart showing
the selection of a study sample
from a 15+ year follow-up clinic of
the Avon Longitudinal Study of
Parents and Children. All
analyses presented in this paper
are based on 2348 participants
with complete data on facial soft
tissue morphology (exposure),
blood-based indicators of insulin
resistance and associated
cardiometabolic risk factors
(outcomes) and body mass index
and pubertal stage (covariables).
Figure 2 Twenty-one anthropometric landmarks which were
identified on facial laser scans of participants. (1) Glabella (g);
(2) Nasion (n); (3) Endocanthion left (enl); (4) Endocanthion
right (enr); (5) Exocanthion left (exl); (6) Exocanthion right
(exr); (7) Palpebrale superius left (psl); (8) Palpebrale
superius right (psr); (9) Palpebrale inferius left (pil); (10)
Palpebrale inferius right (pir); (11) Pronasale (prn); (12)
Subnasale (sn); (13) Alare left (all); (14) Alare right (alr); (15)
Labiale superius (ls); (16) Crista philtri left (cphl); (17) Crista
philtri right (cphr); (18) Labiale inferius (li); (19) Cheilion left
(chl); (20) Cheilion right (chr); (21) Pogonion (pg). Definitions
by Farkas28 were used. Reprinted from the author’s previous
publication with permission from ‘John Wiley and Sons’.
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pubertal stage. In the second model, we adjusted for
age, gender, pubertal stage and BMI and examined how
much this reduced any associations of facial PCs with
the outcomes. Fasting insulin and triglyceride levels
were right (positively) skewed and their logged values
were used in the linear regression models, which
ensured that the model residuals were approximately
normally distributed. The resultant regression coefﬁ-
cients with 95%CI are presented.
In these multivariable analyses, 140 comparisons were
made (14 exposures with 5 outcomes and 2 models). In
initial analyses, we considered the conventional 0.05
level of statistical signiﬁcance. We then adjusted for mul-
tiple comparisons using a Bonferroni correction by div-
iding 0.05 by 140; thus, for these corrected analyses, a p
value of 0.0004 would be considered to be statistically
signiﬁcant at the 0.05 level. All statistical analyses were
performed in SPSS V.17.0 (SPSS Inc).
RESULTS
Table 1 shows the characteristics of the study partici-
pants. The PCA identiﬁed 14 PCs of facial morphology
(table 2). Each PC consisted of a number of coordinates
of anthropometric landmarks. For example, the ﬁrst PC
(PC 1) comprised 17 y coordinates of landmarks located
in the upper and lower thirds of the face. These coordi-
nates represented facial height (size). In order to facili-
tate the understanding and interpretation of individual
PCs, they are presented graphically in ﬁgure 3. The ﬁrst
three PCs (facial size, inter-eye distance and prominence
of the nose and lower lip) accounted for almost half of
the total variation (45.7%). The other 11 PCs contribu-
ted to facial variation to a much lesser extent (between
1.6 and 5%), but marked those subtle features which
make the faces unique.
The multivariable associations of the 14 PCs with car-
diometabolic outcomes are shown in tables 3–7. With
adjustment for age, gender and pubertal stage (model
1), seven PCs were associated with fasting insulin, none
with fasting glucose, three PCs with triglycerides and
HDLc and four PCs with LDLc. After additional adjust-
ment for BMI (model 2), four PCs remained associated
with fasting insulin, none with glucose, one with trigly-
cerides, none with HDLc and two with LDLc. However,
none of these associations withstood adjustment for mul-
tiple comparisons.
DISCUSSION
Laser surface scanning is a non-invasive technology
which enables the accurate and precise analysis of facial
morphology.1 2 24–26 Owing to its portability, easy appli-
cation and relatively low cost, this technique is very suit-
able for epidemiological ﬁeld studies. The vast amount
of data captured by the system (more than 40 000
points, each consisting of x, y and z coordinates) is a tes-
timony to the complexity of facial surfaces. For this
reason, the face cannot be easily represented as a single
exposure.
Therefore, it was necessary to make some facial
data-reduction prior to its meaningful use. First of all,
Table 1 Characteristics of the study sample
Categories/units Males N=1127 Females N=1221 All N=2348
Age
Mean (months) 184.8 (3.0) 184.9 (3.2) 184.9 (3.1)
Tanner’s pubertal stages
Stage I n (%) 0 0 0
Stage II n (%) 8 (0.7) 6 (0.5) 14 (0.6)
Stage III n (%) 64 (5.7) 118 (9.7) 182 (7.8)
Stage IV n (%) 552 (49) 632 (51.8) 1184 (50.4)
Stage V n (%) 503 (44.6) 465 (38.1) 968 (41.2)
BMI
Median (kg/m2) 20.4 (18.9, 22.3) 21.2 (19.5, 23.4) 20.8 (19.1, 23.0)
Fasting insulin
Median (IU/l) 8.2 (5.9, 10.9) 9.7 (7.4, 13.0) 9.0 (6.6, 12.0)
Fasting glucose
Mean (mmol/l) 5.3 (0.4) 5.1 (0.3) 5.2 (0.4)
Total cholesterol
Mean (mmol/l) 3.6 (0.6) 3.9 (0.6) 3.8 (0.6)
Triglycerides
Median (mmol/l) 0.7 (0.6, 1.0) 0.8 (0.6, 1.0) 0.7 (0.6, 1.0)
HDLc
Mean (mmol/l) 1.2 (0.3) 1.4 (0.3) 1.3 (0.3)
LDLc
Mean (mmol/l) 2.0 (0.5) 2.2 (0.6) 2.1 (0.6)
Number (%) for categorical variables, mean (SD) or median (IQR) for continuously distributed variables are presented.
BMI, body mass index; HDLc, high-density lipoprotein cholesterol; LDLc, low-density lipoprotein cholesterol.
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Table 2 The results of the principal component analysis showing partial correlation coefficients between coordinates of anthropometric
landmarks and facial principal components
Facial principal components




























































Only major landmarks contributing to each principal component (PC) are shown (coefficients with absolute values above 0.5). Anthropometric
landmarks are explained in figure 2 and the principal components in figure 3.
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GPA (a widely established method in statistical shape
analysis) was used to place landmark coordinates in the
same space reducing confounding errors (rotation and
translation). Second, PCA was applied on the set of coor-
dinates and 14 facial PCs were identiﬁed, which
accounted for almost 82% of the total variation in
Figure 3 Facial principal components (PCs). Numbers indicate percentages of normal facial variation explained by the given
principal component. Coordinates which constitute each principal component are marked on the face (refer to table 2), and
arrows indicate the x, y and z directions.
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normal facial form, consisting of size and shape. Normal
facial variation was recently analysed on a complete
sample of 4747 faces from the ALSPAC database and the
same number of PCs was extracted, with an almost iden-
tical order of individual PCs and very similar percen-
tages of variation.22
The application of this statistical technique is not new.
Previously, PCA was performed on two-dimensional data
sets, obtained from either lateral skull radiographs or
photographs of both children and adults.38–41 The result-
ant number of PCs in these studies was between 6 and 8,
and these explained up to 90% of the total variance in
facial proﬁle, based on linear measurements between
anthropometric landmarks, or their coordinates.
However, with the introduction of sophisticated 3D
imaging techniques, the amount of data entering PCA
increased signiﬁcantly. Therefore, the number of PCs
which represent facial variation also increased: between
14 and 16 PCs have been reported to account for
between 86% and 92% of the total variation.10 11 41 42
Although the ﬁrst three components in the current
study explain almost half of the total variation, other
components are also important, since they represent
subtle changes that make the face unique. Therefore, a
decision was made to keep all of them in the subsequent
multivariable analyses. Following adjustment for BMI
Table 3 Multivariable association of 14 facial principal components (exposures) with fasting insulin as an outcome
Model 1 Model 2
PC B (95% CI) p Value B (95% CI) p Value
PC1 0.004 (−0.006 to 0.014) 0.397 −0.011 (−0.021 to −0.001) 0.026
PC2 0.011 (0.002 to 0.019) 0.011 −0.003 (−0.011 to 0.005) 0.419
PC3 0.010 (0.002 to 0.019) 0.015 0.002 (−0.006 to 0.010) 0.681
PC4 −0.001 (−0.009 to 0.007) 0.803 0.002 (−0.005 to 0.010) 0.538
PC5 −0.011 (−0.020 to −0.002) 0.019 0.001 (−0.008 to 0.010) 0.802
PC6 0.010 (0.002 to 0.018) 0.013 0.001 (−0.007 to 0.009) 0.787
PC7 0.000 (−0.008 to 0.008) 0.935 0.005 (−0.003 to 0.013) 0.190
PC8 −0.017 (−0.028 to −0.006) 0.003 −0.014 (−0.024 to −0.004) 0.009
PC9 0.012 (0.003 to 0.020) 0.005 0.012 (0.004 to 0.020) 0.002
PC10 0.005 (−0.003 to 0.014) 0.190 0.002 (−0.006 to 0.010) 0.601
PC11 0.026 (0.018 to 0.034) <0.001 0.009 (0.001 to 0.017) 0.029
PC12 0.006 (−0.002 to 0.014) 0.151 0.005 (−0.002 to 0.013) 0.172
PC13 −0.005 (−0.014 to 0.003) 0.220 0.001 (−0.007 to 0.009) 0.867
PC14 −0.003 (−0.011 to 0.005) 0.485 −0.005 (−0.012 to 0.003) 0.236
Model 1 is adjusted for age, gender and puberty (adjusted R2=0.07); model 2 is adjusted for age, gender, puberty and body mass index
(adjusted R2=0.17). PC, principal component of the face (refer to the text, table 2 and figure 3 for an explanation); B, regression coefficient.
Italics indicate statistically significant associations at the level p<0.05 (before Bonferroni corrections).
Table 4 Multivariable association of 14 facial principal components (exposures) with fasting glucose as an outcome
Model 1 Model 2
PC B (95% CI) p Value B (95% CI) p Value
PC1 −0.010 (−0.028 to 0.008) 0.286 −0.017 (−0.035 to 0.001) 0.065
PC2 0.003 (−0.011 to 0.018) 0.674 −0.003 (−0.018 to 0.012) 0.724
PC3 0.010 (−0.005 to 0.025) 0.197 0.006 (−0.009 to 0.021) 0.458
PC4 −0.008 (−0.023 to 0.007) 0.310 −0.006 (−0.021 to 0.009) 0.427
PC5 0.002 (−0.014 to 0.019) 0.769 0.007 (−0.009 to 0.024) 0.381
PC6 0.012 (−0.003 to 0.026) 0.115 0.009 (−0.006 to 0.023) 0.243
PC7 0.009 (−0.006 to 0.023) 0.226 0.011 (−0.004 to 0.025) 0.147
PC8 −0.002 (−0.016 to 0.013) 0.808 −0.001 (−0.015 to 0.014) 0.924
PC9 −0.004 (−0.018 to 0.011) 0.613 −0.003 (−0.018 to 0.011) 0.657
PC10 −0.011 (−0.026 to 0.003) 0.124 −0.013 (−0.027 to 0.002) 0.083
PC11 0.008 (−0.007 to 0.023) 0.301 0.002 (−0.014 to 0.017) 0.838
PC12 0.005 (−0.010 to 0.019) 0.535 0.005 (−0.010 to 0.019) 0.521
PC13 0.003 (−0.013 to 0.018) 0.730 0.004 (−0.011 to 0.020) 0.563
PC14 0.001 (−0.013 to 0.016) 0.866 0.002 (−0.013 to 0.016) 0.812
Model 1 is adjusted for age, gender and puberty (adjusted R2=0.05); model 2 is adjusted for age, gender, puberty and body mass index
(adjusted R2=0.06). PC, principal component of the face (refer to the text, table 2 and figure 3 for an explanation); B, regression coefficient.
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and taking account of multiple statistical testing, we did
not ﬁnd that any of these PCs were associated with
fasting insulin or associated cardiometabolic risk factors,
suggesting that facial morphology is unlikely to be a reli-
able way of predicting young people at future risk of
type 2 diabetes or cardiovascular disease. Consistent with
other large epidemiological studies conducted in
healthy general population samples, we were not able to
directly measure insulin resistance using the gold stand-
ard euglycaemic hyperinsulinaemic clamp. Fasting
insulin has been shown to have modest-to-strong correla-
tions with clamp-assessed insulin resistance (correlation
coefﬁcients 0.5–0.9) in children and adolescents.43 44
Any measurement error is likely to be non-differential
and therefore would be expected to bias results towards
the null. Since strong associations of these outcomes
with BMI have been shown in ALSPAC,23 any associa-
tions with a better measure of insulin resistance are
unlikely to be stronger than those of BMI.
The study has some limitations. First of all, it is ethnic-
speciﬁc, and therefore future studies will have to address
the research question in different ethnic groups.
Second, facial variation can be affected by many differ-
ent factors. While it is possible to control the age,
gender and ethnicity of the sample, environmental
factors present a greater challenge, even with a good
Table 5 Multivariable association of 14 facial principal components (exposures) with triglycerides as an outcome
Model 1 Model 2
PC B (95% CI) p Value B (95% CI) p Value
PC1 0.010 (−0.001 to 0.020) 0.073 0.000 (−0.011 to 0.010) 0.975
PC2 0.004 (−0.003 to 0.010) 0.291 −0.003 (−0.010 to 0.003) 0.351
PC3 0.008 (0.001 to 0.015) 0.019 0.004 (−0.003 to 0.010) 0.287
PC4 −0.005 (−0.001 to 0.002) 0.177 −0.003 (−0.009 to 0.004) 0.397
PC5 −0.001 (−0.008 to 0.007) 0.818 0.005 (−0.002 to 0.012) 0.193
PC6 0.011 (0.004 to 0.017) 0.001 0.007 (0.000 to 0.013) 0.045
PC7 0.000 (−0.007 to 0.006) 0.945 0.002 (−0.005 to 0.008) 0.563
PC8 −0.005 (−0.012 to 0.001) 0.118 −0.004 (−0.011 to 0.002) 0.206
PC9 0.005 (−0.001 to 0.012) 0.113 0.006 (−0.001 to 0.012) 0.086
PC10 0.005 (−0.001 to 0.012) 0.113 0.004 (−0.003 to 0.010) 0.263
PC11 0.008 (0.001 to 0.014) 0.024 <0.001 (−0.007 to 0.007) 0.988
PC12 −0.003 (−0.010 to 0.003) 0.341 −0.003 (−0.010 to 0.003) 0.317
PC13 −0.004 (−0.011 to 0.003) 0.213 −0.002 (−0.009 to 0.005) 0.601
PC14 −0.005 (−0.011 to 0.002) 0.143 −0.005 (−0.012 to 0.001) 0.118
Model 1 is adjusted for age, gender and puberty (adjusted R2=0.03); model 2 is adjusted for age, gender, puberty and body mass index
(adjusted R2=0.06). PC, principal component of the face (refer to the text, table 2 and figure 3 for an explanation); B, regression coefficient.
Italics indicate statistically significant associations at the level p<0.05 (before Bonferroni corrections).
Table 6 Multivariable association of 14 facial principal components (exposures) with high-density lipoprotein cholesterol as
an outcome
Model 1 Model 2
PC B (95% CI) p Value B (95% CI) p Value
PC1 −0.028 (−0.042 to −0.014) <0.001 −0.013 (−0.027 to 0.001) 0.073
PC2 −0.005 (−0.017 to 0.006) 0.351 0.008 (−0.003 to 0.020) 0.154
PC3 −0.006 (−0.017 to 0.006) 0.339 0.003 (−0.008 to 0.014) 0.611
PC4 0.007 (−0.004 to 0.019) 0.228 0.004 (−0.008 to 0.015) 0.538
PC5 0.007 (−0.006 to 0.020) 0.279 −0.005 (−0.018 to 0.008) 0.443
PC6 −0.014 (−0.025 to −0.003) 0.016 −0.005 (−0.016 to 0.006) 0.408
PC7 0.003 (−0.008 to 0.015) 0.570 −0.001 (−0.012 to 0.010) 0.797
PC8 0.009 (−0.003 to 0.020) 0.129 0.007 (−0.004 to 0.018) 0.205
PC9 0.001 (−0.010 to 0.012) 0.883 0.000 (−0.011 to 0.011) 0.940
PC10 −0.010 (−0.022 to 0.001) 0.078 −0.007 (−0.018 to 0.004) 0.229
PC11 −0.022 (−0.034 to −0.011) <0.001 −0.006 (−0.017 to 0.006) 0.340
PC12 0.005 (−0.007 to 0.016) 0.413 0.005 (−0.006 to 0.016) 0.348
PC13 0.005 (−0.007 to 0.017) 0.387 −0.001 (−0.012 to 0.011) 0.905
PC14 0.000 (−0.012 to 0.011) 0.959 0.001 (−0.010 to 0.012) 0.798
Model 1 is adjusted for age, gender and puberty (adjusted R2=0.08); model 2 is adjusted for age, gender, puberty and body mass index
(adjusted R2=0.13). PC, principal component of the face (refer to the text, table 2 and figure 3 for an explanation); B, regression coefficient.
Italics indicate statistically significant associations at the level p<0.05 (before Bonferroni corrections).
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research strategy, as many of them can be unknown at
the time of the study. The face changes throughout life,
increasing in size and changing in shape.1 2 7 This holds
true for the present sample consisting of 15-year-old ado-
lescents. The cross-sectional design of the study did not
allow us to track these changes and analyse their rela-
tionship with metabolic phenotype through time. That
may be more important than the assessment of variation
among individuals and thus should be considered in
future studies.
CONCLUSION
Our results do not provide strong evidence that facial
morphology is robustly and importantly associated with
cardiometabolic risk factors. The associations identiﬁed
were not consistent across outcomes, were weak in magni-
tude, attenuated with adjustment for BMI, and did not
withstand correction for multiple statistical testing. Further
study of facial parameters with cardiometabolic and/or
other health outcomes might provide valuable insights
into how facial morphology can be indicative of health.
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